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Introduction {#sec1-1}
============

Glaucoma ranks the second leading cause for irreversible blindness in the world (Weinreb and Khaw, 2004; Zhang et al., 2012a). The most important symptom of glaucoma is the gradual vision loss from peripheral to central field of the eyes. There are different types of glaucoma and the most common type is open-angle glaucoma in which the drainage of aqueous humor is blocked and eye pressure rises to induce injury to retinal ganglion cells (RGCs) (Liebmann and Lee, 2017). There is also normal-tension-type glaucoma and the precise mechanisms of RGC death were not clear in this type although several possible factors of pathogenesis have been put forward (Killer and Pircher, 2018). Nevertheless, for most glaucoma patients, the common and only effective treatment is to reduce the intraocular pressure by surgery or drugs, even in normal hypertension glaucoma patients. However, even the intraocular hypertension is reduced, RGCs will continue to die and the vision loss will further deteriorate in some patients. Therefore, except for primary degeneration, secondary degeneration is believed to exist in glaucoma (Calkins, 2012; Li et al., 2014).

To study primary and secondary degeneration in specific locations in the retina, a new partial optic nerve transection (PONT) model in monkeys and rats was established in the first decade of this century. Two main points had been verified using this model: one is the existence of secondary degeneration, and the other is the distribution pattern of primary and secondary degeneration in the retina (Levkovitch-Verbin et al., 2001; Levkovitch-Verbin et al., 2003; O'Hare Doig et al., 2017). Previous studies using the PONT model have demonstrated that the death mechanisms between primary and secondary degeneration of RGCs are different. For example, the polysaccharides from *Lycium barbarum* (LBP) exert neuroprotective effect only on RGCs which would die from secondary degeneration but not on those would die from primary degeneration (Li et al., 2013, 2015). Recently, Chiha et al. (2018) showed the difference in the retinal gene activation nature after PONT between the region vulnerable to primary degeneration and the one vulnerable to secondary degeneration. All these findings support that the mechanisms of RGC death are different between primary and secondary degeneration after PONT.

Exercise has been shown to be beneficial for central nervous system (CNS) diseases in both human and animal models. There are various styles of exercise, such as swimming, dancing, running and walking. The role of exercise has been detected in the following CNS disease models: Parkinson's disease (Crowley et al., 2018), amyotrophic lateral sclerosis (Desseille et al., 2017), cerebral ischemia (Gabriel-Salazar et al., 2018), dementia (Kurucz et al., 2018), and depression (Yau et al., 2014a). Voluntary running is a kind of exercise which is common in human daily life, and this method is also used in animal studies to imitate human actual exercise.

Previous studies showed that voluntary running improved cognitive dysfunction, increased the production of neurotrophic factors in a rat model of Parkinson's disease (Hsueh et al., 2018), increased neurogenesis in the brains of rat models of depression (Yau et al., 2014a, b), increased the production of anti-oxidant enzyme HO-1 in the brains of rat models of dementia (Kurucz et al., 2018), and up-regulated the production of Sirt3 in cortical neurons. Lacking of voluntary running has been reported to increase the vulnerability to oxidative stress and excitotoxicity (Cheng et al., 2016). All these results point to a conclusion that exercise is beneficial for different CNS diseases through various mechanisms.

Glaucoma is a disease characterized by the death of RGCs which is caused by multiple factors, including deprivation of neurotrophic factors (Sleeman et al., 2000; Ghaffariyeh et al., 2011; Levkovitch-Verbin, 2015), oxidative stress (Pinazo-Duran et al., 2015; Giacci et al., 2018), excitotoxicity (Ju et al., 2009; Lee et al., 2014); inflammation (Takada et al., 2011; Husain et al., 2012; Vohra et al., 2013), and apoptosis (Levkovitch-Verbin, 2015). Among these factors, several could be modulated by voluntary running as mentioned above, therefore, we hypothesized that voluntary running would be beneficial in glaucoma model by modulating these pathways although whether it would act on primary or secondary degeneration or both remained unknown.

Materials and Methods {#sec1-2}
=====================

Animals and housing conditions {#sec2-1}
------------------------------

The experimental plan was approved by the Committee on the Use of Live Animals in Teaching and Research at the University of Hong Kong (Animal license \#14-465 approved on May 5, 2014) and given a license by the Jinan University Institutional Animal Care and Use Committee.

Adult Sprague-Dawley (SD) rats, aged 10--12 weeks, weighing 250--280 g, were housed individually in cages with a locked wheel (non-runners) or unlocked wheel (runners). All animals were maintained on a 12-hour light/dark cycle with ad libitum access to water and food. In this study, animals (*n* = 4 to 6/group, total 30 rats) were used for the following three experiments: 1) To compare the RGC survival 4 weeks after PONT in runners and non-runners, the schedule of treatments and animal allocation are demonstrated in [**Figure 1A**](#F1){ref-type="fig"}. The PONT surgery (detailed procedure described below) was administrated on the day after 4 weeks of voluntary running. After the surgery, the runners would continue voluntary running for 4 more weeks. RGC retrograde labeling from superior colliculi (SC) was administrated 1 week before euthanasia. Then all rats would be euthanatized after the cease of voluntary running. 2) To detect the changes in the protein levels of MnSOD and p-JNKs in the superior retina since the changes in the inferior retina had been detected and reported in a previous study (Li et al., 2013); and to detect the protein levels of glutamine synthetase (GS) both in the superior and inferior retinas 1 day after PONT (The timeline of treatments and animal grouping are illustrated in [**Figure 1B**](#F1){ref-type="fig"}). 3) To compare the changes in the expression levels of these proteins between the runners and non-runners and the schedule of treatments and animal grouping are shown in [**Figure 1C**](#F1){ref-type="fig"}. The PONT surgery was administrated after voluntary running ceased and the rats were euthanized 1 day after PONT.

![Schematic diagrams demonstrating the experimental procedure.\
(A) After 2 days of adaptation, rats were housed individually with either unlocked or locked wheels for 28 days. PONT was administrated on day 30. On day 52, fluoro-gold (FG) was used to label RGCs; on day 59, rats were euthanized for RGC counting. (B) The rats were administrated with PONT on day 0 and euthanized 1 day after PONT for western blot (WB) analysis. (C) After 2 days of adaptation, rats were housed individually with either unlocked or locked wheels for 28 days. The rats were administrated with PONT after completion of voluntary running and euthanized 24 hours after surgery for WB analysis. (D) Comparison of the average daily running distance between rats used for detection of RGC survival and those used for western blot analysis. The average daily running distance was 4.9 ± 0.8 km/day across rats used for RGC survival detection and it was 5.6 ± 0.6 km/day across rats used for WB analysis. There was no significant difference between these two groups (D). NS: not significant; *n* = 6 in each group; mean ± SEM. RGCs: Retinal ganglion cells; PONT: partial optic nerve transection.](NRR-14-728-g001){#F1}

Exercise training {#sec2-2}
-----------------

The running system for rats in this study was used in several reports (Yau et al., 2012, 2014a; Lee et al., 2016). Runners were housed in cages individually with unlocked wheels (diameter, 31.8 cm; width, 10 cm; Nalgene Nunc International, Rochester, NY, USA), while non-runners were housed in cages with locked wheels as well as other similar conditions. Turns of wheel were recorded using the VitalViewer software per hour (Mini Mitter Company, Inc, Bend, OR, USA). The perimeter of the wheel was used as the length of running per turn. Then the average daily running distance (km/day) was calculated for each animal both in the group used for western blot analysis and in the group used for RGC survival estimation. The time points for locking and unlocking management are demonstrated in **Figure** [**1A**](#F1){ref-type="fig"} & [**B**](#F1){ref-type="fig"}.

PONT surgery {#sec2-3}
------------

The PONT surgery was described previously (Chu et al., 2013; Li et al., 2013, 2014, 2015). Before surgery, SD rats were anesthetized with ketamine (80 mg/kg) and xylazine (8 mg/kg) *via* intraperitoneal injection. Sterile eye lubricant ointment was applied to prevent drying of the corneas during surgery. The partial incision in the optic nerve was cut 1.0 mm from the optic disc and was completed using a diamond knife (G-31480, Geuder AG, Hertzstrasse, Heldelberg, Germany) with the blade fixed to a length of 200 μm. After surgery, ophthalmic ointment (0.3% tobramycin) was applied to the cornea to reduce inflammation, and the fundus of the eyes was inspected to ensure that the retinal blood supply was not compromised by the surgery (Chu et al., 2013). The buprenorphine (100 mg/kg) was added to the drinking water for 7 days after the surgery to reduce the pain of animals. The exclusion criterion was the compromise of the blood supply after surgery.

Superior colliculi labeling {#sec2-4}
---------------------------

Superior colliculi labeling was conducted 1 week before euthanasia according to a previously described method (Chiu et al., 2008; Li et al., 2013). In brief, before surgery, SD rats were anesthetized with ketamine (80 mg/kg) and xylazine (8 mg/kg) via intraperitoneal injection. Then the rat scalp was cut open in the mid-line and the sagittal, coronal and transverse sutures of the skull were exposed. Two skull holes with the area of 4 × 4 mm^2^ and 0.5 mm from both sagittal and transverse sutures were drilled on both sides of the sagittal suture. The brain tissue covering the superior colliculi was sucked away using a vacuum pump until four borders of superior colliculi could be seen under microscope. Then a thin layer of gel-foam soaked with 6% Fluro-Gold was spread on the surface of superior colliculi for labeling of RGCs. The space of the hole was filled with gel foam and the skin was closed with suture clips. After surgery, buprenorphine (100 mg/kg) was added to the drinking water for 7 days or until euthanasia to alleviate the pain of animals.

Quantification of RGCs {#sec2-5}
----------------------

Preparation of retinas for quantification of RGCs was the same as described previously (Li et al., 2013). After euthanasia, retinas were post-fixed in 4% paraformaldehyde for 1 hour and divided into the superior and inferior halves. Either half was cut into three sectors (roughly equal) before being flat-mounted. Eight photographs with the size of 200 × 200 µm^2^ in each sector were obtained along the median line, from the optic disc to the borders at 500 µm intervals under microscope (DM6000 B, Leica, Wetzlar, Germany) at 400× magnification. Therefore, a total 24 photographs were counted in either half to obtain the average number of RGCs in each photograph (0.04 mm^2^). Then the densities of surviving RGCs per mm^2^ were calculated for either half. All photographs were quantified by two persons using a double-blind manner.

Western blot analysis {#sec2-6}
---------------------

At 1 day after PONT, we detected protein expression and investigated the effects of voluntary running on protein expression because protein changes had been observed as early as this time point after PONT in the previous studies (Fitzgerald et al., 2010; Li et al., 2013). After euthanasia, the superior and inferior retinas were collected individually in 0.01 M sterilized PBS on ice. All agents used were as described previously (Li et al., 2013). After transferring the proteins onto the polyvinylidenedifluoride (PVDF) membranes, the membranes were blocked with 5% non-fat dry milk or 3% bovine serum albumin in Tris-buffered saline with 0.05% Tween 20 for 1 hour. Mouse monoclonal antibody manganese superoxide dismutase (MnSOD or SOD2, 1:20 000) was supplied by Abcam (Cambridge, MA, USA). Rabbit polyclonal phospho-c-jun N-terminal kinases (p-JNKs, 1:500), JNK (1:500) and glyeraldehayde-3-phosphate-dehydrogenase (GAPDH, 1:10,000) antibodies were bought from Cell Signaling Technology (Beverly, MA, USA). Mouse monoclonal antibody glutamine synthetase (GS, 1:10,000) was purchased from Millipore (Billerica, MA, USA). The primary antibodies were incubated in Tris-buffered saline with 0.05% Tween 20 overnight at 4°C. The secondary antibodies (dilution 1:10,000 for MnSOD and GS and 1:2000 for others) were incubated for 1 hour at room temperature. Protein loading was controlled using the monoclonal mouse antibody against alpha-tubulin (1:20 000, Sigma-Aldrich, St. Louis, MO, USA) or GAPDH (1:10000). Densitometric analysis was conducted using ImageJ software (National Institutes of Health, Bethesda, MD, USA) on the autoradiographic photographs acquired from the ChemiDoc™ Touch Imaging System (Bio-Rad, Hercules, California, USA).

Statistical analysis {#sec2-7}
--------------------

Data were compared between two groups. Student's *t*-test was utilized. Data were statistically analyzed using the Sigmastat software (Sigmastat 3.5; Systat Software Inc., Chicago, IL, USA). The level of *P* \< 0.05 was decided to be statistically significant. All data are expressed as the mean ± SEM.

Results {#sec1-3}
=======

Running distance of runners {#sec2-8}
---------------------------

The average daily running distance of runners was 4.9 ± 0.8 km/day in rats used for RGC survival estimation and it was 5.6 ± 0.6 km/day in rats used for western blot analysis. There was no significant difference in running distance between these two groups ([**Figure 1D**](#F1){ref-type="fig"}).

The RGC survival rates in the superior and inferior retinas of both non-runners and runners 4 weeks after PONT {#sec2-9}
--------------------------------------------------------------------------------------------------------------

The densities of RGCs in the superior retina of non-runner (*n* = 5, one rat died after anesthesia for PONT) and runners (*n* = 6) were: 828 ± 182 RGCs/mm^2^ and 1345 ± 106 RGCs/mm^2^, respectively. The number of surviving RGCs in the superior retina in runners significantly increased compared with that in non-runners (*P* \< 0.05, **Figure** [**2A**](#F2){ref-type="fig"}--[**C**](#F2){ref-type="fig"}). The densities of existing RGCs in the inferior retina of non-runner and runners were: 855 ± 120 RGCs/mm^2^ and 1024 ± 178 RGCs/mm^2^, respectively. There were no significant differences in the densities of RGCs in the superior and inferior retina between non-runners and runners (*P* \> 0.05; **Figure** [**2A**](#F2){ref-type="fig"}, [**D**](#F2){ref-type="fig"} & [**E**](#F2){ref-type="fig"}).

![Comparisons of surviving RGCs both in the superior and inferior retinas between non-runners and runners 4 weeks after PONT.\
(A) Comparisons of densities of surviving RGCs both in the superior and inferior retinas between non-runners and runners 4 weeks after PONT. The densities of RGCs in the superior retina of non-runners were significantly decreased compared with those in runners (Student's *t*-test, \**P* \< 0.05). There was no significant difference in RGC density in the inferior retina between non-runners and runners (Student's *t*-test, *P* \> 0.05). *n* = 5 in the non-runner group and *n* = 6 in the runner group. NS: Not significant. Data are expressed as the mean ± SEM. (B, C) Representative photographs of surviving RGCs in the superior retina in the non-runner and runner groups. (D, E) Representative photographs of surviving RGCs in the inferior retina in the non-runner and runner groups. The RGCs in B--E were labeled by fluoro-gold. RGCs: Retinal ganglion cells; PONT: partial optic nerve transection.](NRR-14-728-g002){#F2}

The expression pattern of MnSOD, GS, and p-JNKs in the retina of non-injured rats and the rats subjected to PONT 1 day after surgery {#sec2-10}
------------------------------------------------------------------------------------------------------------------------------------

At 1 day after PONT, the protein levels of MnSOD and p-JNK2/3 in the inferior retinas increased (Li et al., 2013). Results from this study showed that the protein level of MnSOD in the superior retinas also increased 1 day after PONT ([**Figure 3A**](#F3){ref-type="fig"}). The expression of p-JNK2/3 increased but p-JNK1 did not change in the superior retinas ([**Figure 3B**](#F3){ref-type="fig"}). The expression of GS increased in the superior retinas, but not in the inferior retinas 1 day after PONT ([**Figure 3C**](#F3){ref-type="fig"}).

![Comparisons of MnSOD, p-JNKs and GS expression between normal retinas and the retinas from rats subjected to PONT 1 day after surgery.\
(A) There was significant difference in MnSOD expression in the superior retina between normal rats and the rats subjected to PONT. (B) There were no significant differences in p-JNK1 and p-JNK2/3 expression in the superior retina between normal rats and the rats subjected to PONT. (C) Significant difference in GS expression both in the superior and inferior retinas was observed between normal rats and the rats subjected to PONT. There were four rats in each group; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; mean ± SEM. NS: Not significant; PONT: partial optic nerve transection; p-JNKs: phospho-c-Jun N-terminal kinases; MnSOD: manganese superoxide dismutase; GS: glutamine synthetase.](NRR-14-728-g003){#F3}

The expression pattern of MnSOD, GS, and p-JNKs in the retina of non-runners and runners 1 day after PONT {#sec2-11}
---------------------------------------------------------------------------------------------------------

After 4 weeks of voluntary running, there were no significant differences in MnSOD and p-JNKs expression in the superior retina between runners and non-runners 1 day after PONT (**Figure** [**4A**](#F4){ref-type="fig"} and [**C**](#F4){ref-type="fig"}). The density of GS bands decreased in the superior retina but not in the inferior retina in runners ([**Figure 4B**](#F4){ref-type="fig"}).

![Comparisons of MnSOD, p-JNKs and GS expression in the superior retinas between non-runners and runners.\
(A) There was no significant difference in MnSOD expression in the superior retina between non-runners and runners 1 day after PONT. (B) There were no significant differences in p-JNK1 and p-JNK2/3 expression levels in the superior retina between non-runners and runners. (C) A significant difference in GS expression was detected in the superior retina but not in the inferior retina at 1 day after PONT between non-runners and runners. There were five rats in the non-runner group and six rats in the runner group. \**P* \< 0.05; mean ± SEM. NS: Not significant; PONT: partial optic nerve transection; p-JNKs: phospho-c-Jun N-terminal kinases; MnSOD: manganese superoxide dismutase; GS: glutamine synthetase.](NRR-14-728-g004){#F4}

Discussion {#sec1-4}
==========

The average daily running distance in the group used for estimation of RGC survival and the group used for western blot analysis was estimated. Results showed that there was no significant difference between these two groups. The running exercise in these two groups was conducted at different time periods. The data shows that the average daily running distances are comparable between different runners who ran at different time periods.

Results from this study showed that voluntary running could delay RGC degeneration in the superior retina but not in the inferior retina. This suggests that voluntary running mainly delayed primary degeneration of RGCs but not secondary degeneration since we found that most primary degeneration occurred in the superior retina and secondary degeneration mainly occurred in the inferior retina (Li et al., 2013).

In this study, we used rat models of PONT. In a previous study, oxidative stress was involved in both the primary and secondary degeneration after PONT and increased MnSOD could be detected as fast as 5 minutes after PONT and maintained at least 3 days after PONT (MnSOD at later time points was not detected in this study) (Fitzgerald et al., 2010). Therefore, we chose 1 day after PONT as the time point for analyzing the effects of voluntary running on oxidative stress. Since excitotoxicity was often thought to be related with oxidative stress (Bondy and LeBel, 1993; Lee et al., 2014), so we also wanted to detect the excitotoxicity simultaneously. The excitatory neurotransmitter glutamate in the retina is mainly taken up and degraded to nontoxic glutamine by Müller cells in the retinas. If the metabolism of glutamate is abnormal, then excitotoxicity will occur. The increase in extracellular level of glutamate could up-regulate GS. Therefore, the increase in GS after PONT might suggest excess glutamate after PONT (Ishikawa, 2013).

Glutamate is secreted by photoreceptors and bipolar cells in the retinas. Increased glutamate level indicates the malfunction or degeneration of photoreceptors or bipolar cells after PONT. This has been verified in a previous study involving the same model (Chu et al., 2013). Therefore, GS up-regulation indirectly indicates the existence of excitotoxicity in primary degeneration region after PONT. In this study, up-regulation of GS is only detected in the primary degeneration region but not in the secondary degeneration region. This is consistent with a recent study by Chiha et al. (2018). Chiha et al. (2018) found the gene related with excitotoxicity changed obviously in the primary degeneration region but not in the secondary degeneration region. Both results show that excitotoxicity is involved in primary degeneration of RGCs and that the mechanism underlying primary degeneration of RGCs should be different from that underlying secondary degeneration of RGCs.

In this study, we also identified the increase of MnSOD in primary degeneration area. But what surprises us is that voluntary running has effect only on GS but not on MnSOD in the superior retinas after PONT, suggesting that excitotoxicity can occur independently of oxidative stress. Although this explanation is contrary to the opinion in most related publications, Boldyrev et al. (1999) pointed out that excitotoxicity death could be independent of oxidative stress in their study. In addition, although the involvement of JNK pathway in RGC death was proved in a previous study (Tezel et al., 2004; Wakabayashi et al., 2005; Kim et al., 2013) and in this study, the neuroprotective effect of voluntary running was not dependent on this pathway. This is consistent with a recent study by Fahrenthold et al. (2018) who reported that excitotoxicity to RGCs induced by N-methyl-D-aspartate (NMDA) could not be attenuated when JNK component was absent. This result indicates that excitotoxicity is not mediated by JNK pathway and the initial driver of it remains unknown. Therefore, it is possible that voluntary running can only influence excitotoxicity, but not oxidative stress, in RGC protection and this pathway is independent of the JNK pathway. The possible explanation for voluntary running influencing GS is that the degradation of glutamate needs ATP to supply the energy (Ishikawa, 2013). More ATP is produced when there is enough oxygen. One important role of exercise is to increase the blood supply of organs and to provide more oxygen to the retina (Zhang et al., 2012b), therefore supply of enough energy promotes the degradation of glutamate in this case and protects RGCs from degeneration. There is also another possibility that GS down-regulation after voluntary running is an indirect result of less RGC death. This study may provide a potential direction when considering the mechanisms of RGC death and the neuroprotective measures.

In summary, these data demonstrate that voluntary running can delay primary degeneration, but not secondary degeneration, of RGCs. This finding is significant since there is currently a lack of intervention which clearly demonstrates the delay of primary degeneration of RGCs following optic nerve damage. However, neuroprotection for RGCs which will die from secondary degeneration is important because degeneration of RGCs will continue for a long time period after the primary damage stops. In previous research, the polysaccharides extracted from Lycium barbarum (LBP) is found to delay secondary, but not primary, degeneration after PONT, therefore in future we will investigate the combined effects of voluntary running and LBP on the retinas after PONT.
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